ICON Cash on Hand 2010-2025 | ICLR
ICON cash on hand from 2010 to 2025. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
- ICON cash on hand for the quarter ending March 31, 2025 was $0.527B, a 32.32% increase year-over-year.
- ICON cash on hand for 2024 was $0.539B, a 41.76% increase from 2023.
- ICON cash on hand for 2023 was $0.38B, a 30.84% increase from 2022.
- ICON cash on hand for 2022 was $0.29B, a 61.47% decline from 2021.
| ICON Annual Cash on Hand (Millions of US $) |
|
|---|---|
| 2024 | $539 |
| 2023 | $380 |
| 2022 | $290 |
| 2021 | $754 |
| 2020 | $842 |
| 2019 | $570 |
| 2018 | $456 |
| 2017 | $360 |
| 2016 | $261 |
| 2015 | $190 |
| 2014 | $216 |
| 2013 | $321 |
| 2012 | $190 |
| 2011 | $174 |
| 2010 | $256 |
| 2009 | $194 |
| ICON Quarterly Cash on Hand (Millions of US $) |
|
|---|---|
| 2025-03-31 | $527 |
| 2024-12-31 | $539 |
| 2024-09-30 | $696 |
| 2024-06-30 | $507 |
| 2024-03-31 | $398 |
| 2023-12-31 | $380 |
| 2023-09-30 | $315 |
| 2023-06-30 | $272 |
| 2023-03-31 | $282 |
| 2022-12-31 | $290 |
| 2022-09-30 | $611 |
| 2022-06-30 | $617 |
| 2022-03-31 | $561 |
| 2021-12-31 | $754 |
| 2021-09-30 | $1,010 |
| 2021-06-30 | $1,057 |
| 2021-03-31 | $944 |
| 2020-12-31 | $842 |
| 2020-09-30 | $710 |
| 2020-06-30 | $594 |
| 2020-03-31 | $484 |
| 2019-12-31 | $570 |
| 2019-09-30 | $471 |
| 2019-06-30 | $431 |
| 2019-03-31 | $478 |
| 2018-12-31 | $456 |
| 2018-09-30 | $491 |
| 2018-06-30 | $373 |
| 2018-03-31 | $354 |
| 2017-12-31 | $360 |
| 2017-09-30 | $292 |
| 2017-06-30 | $315 |
| 2017-03-31 | $319 |
| 2016-12-31 | $261 |
| 2016-09-30 | $304 |
| 2016-06-30 | $251 |
| 2016-03-31 | $248 |
| 2015-12-31 | $190 |
| 2015-09-30 | $317 |
| 2015-06-30 | $192 |
| 2015-03-31 | $192 |
| 2014-12-31 | $216 |
| 2014-09-30 | $249 |
| 2014-06-30 | $175 |
| 2014-03-31 | $364 |
| 2013-12-31 | $321 |
| 2013-09-30 | $219 |
| 2013-06-30 | $184 |
| 2013-03-31 | $200 |
| 2012-12-31 | $190 |
| 2012-09-30 | $180 |
| 2012-06-30 | $168 |
| 2012-03-31 | $206 |
| 2011-12-31 | $174 |
| 2011-09-30 | $166 |
| 2011-06-30 | $216 |
| 2011-03-31 | $232 |
| 2010-12-31 | $256 |
| 2010-09-30 | $231 |
| 2010-06-30 | $221 |
| 2010-03-31 | $200 |
| 2009-12-31 | $194 |
| 2009-09-30 | $173 |
| 2009-06-30 | $147 |
| 2009-03-31 | $97 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $11.674B | $8.282B |
| ICON plc is a global full service clinical research organisation. The company provides contract clinical research services to the pharmaceutical industry worldwide. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $142.275B | 26.68 |
| CVS Health (CVS) | United States | $86.641B | 10.77 |
| Elevance Health (ELV) | United States | $86.192B | 11.12 |
| Cencora (COR) | United States | $58.034B | 20.19 |
| DiDi Global (DIDIY) | China | $23.015B | 24.45 |
| Natera (NTRA) | United States | $22.934B | 0.00 |
| Labcorp Holdings (LH) | United States | $21.811B | 17.69 |
| BioMerieux (BMXMF) | France | $16.861B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.798B | 0.00 |
| Solventum (SOLV) | United States | $13.056B | 13.82 |
| CochLear (CHEOY) | Australia | $12.649B | 0.00 |
| Revvity (RVTY) | United States | $11.530B | 19.84 |
| Viatris (VTRS) | United States | $10.575B | 3.63 |
| Avantor (AVTR) | United States | $9.220B | 13.40 |
| HealthEquity (HQY) | United States | $9.070B | 39.73 |
| Medpace Holdings (MEDP) | United States | $8.930B | 23.72 |
| Sonic Healthcare (SKHHY) | Australia | $8.455B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.368B | 14.44 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $4.386B | 25.83 |
| BrightSpring Health Services (BTSG) | United States | $4.138B | 37.97 |
| Sotera Health (SHC) | United States | $3.213B | 18.26 |
| Surgery Partners (SGRY) | United States | $2.813B | 36.58 |
| Alignment Healthcare (ALHC) | United States | $2.740B | 0.00 |
| Concentras Parent (CON) | United States | $2.711B | 15.67 |
| GeneDx Holdings (WGS) | United States | $2.599B | 100.11 |
| Organon (OGN) | United States | $2.563B | 2.72 |
| PACS (PACS) | United States | $1.980B | 0.00 |
| Ardent Health (ARDT) | United States | $1.957B | 8.34 |
| Progyny (PGNY) | United States | $1.878B | 41.34 |
| Premier (PINC) | United States | $1.779B | 13.51 |
| GoodRx Holdings (GDRX) | United States | $1.750B | 35.00 |
| Teladoc Health (TDOC) | United States | $1.475B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.205B | 9.17 |
| Establishment Labs Holdings (ESTA) | $1.184B | 0.00 | |
| CareDx (CDNA) | United States | $1.071B | 16.72 |
| Agilon Health (AGL) | United States | $0.956B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.919B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.840B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.799B | 7.48 |
| Nutex Health (NUTX) | United States | $0.683B | 10.34 |
| LifeMD (LFMD) | United States | $0.625B | 0.00 |
| Embecta (EMBC) | United States | $0.563B | 3.80 |
| InnovAge Holding (INNV) | United States | $0.529B | 0.00 |
| Enhabit (EHAB) | United States | $0.484B | 39.83 |
| SBC Medicals (SBC) | United States | $0.481B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.475B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.469B | 10.57 |
| Omada Health (OMDA) | $0.453B | 0.00 | |
| Performant Healthcare (PHLT) | United States | $0.313B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.259B | 0.00 |
| Beauty Health (SKIN) | United States | $0.246B | 0.00 |
| So-Young (SY) | China | $0.240B | 0.00 |
| Oncology Institute (TOI) | United States | $0.195B | 0.00 |
| DocGo (DCGO) | United States | $0.163B | 26.67 |
| Sera Prognostics (SERA) | United States | $0.154B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.120B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.092B | 0.00 |
| KindlyMD (NAKA) | United States | $0.086B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.063B | 0.00 |
| NeueHealth (NEUE) | United States | $0.062B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.056B | 0.00 |
| ModivCare (MODV) | United States | $0.049B | 0.00 |
| Biodesix (BDSX) | United States | $0.037B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.034B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.032B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.011B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |